Lundbeck
HLUN-B.CO
#2582
Rank
A$8.60 B
Marketcap
$9.03
Share price
-0.98%
Change (1 day)
29.18%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total assets

Total assets on the balance sheet as of September 2024 : A$9.47 Billion

According to Lundbeck 's latest financial reports the company's total assets are A$9.47 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Lundbeck - Total assets on balance sheet (from 2009 to 2024)

Total assets by year

Year Total assets Change
2023-12-31A$8.13 B2.6%
2022-12-31A$7.92 B8.91%
2021-12-31A$7.27 B-6.04%
2020-12-31A$7.74 B-5.15%
2019-12-31A$8.16 B63.17%
2018-12-31A$5.00 B22.67%
2017-12-31A$4.07 B2.77%
2016-12-31A$3.96 B-7.46%
2015-12-31A$4.28 B-16.16%
2014-12-31A$5.11 B4.23%
2013-12-31A$4.90 B33.41%
2012-12-31A$3.67 B5.46%
2011-12-31A$3.48 B10.29%
2010-12-31A$3.16 B-13.87%
2009-12-31A$3.67 B10.16%
2008-12-31A$3.33 B20.83%
2007-12-31A$2.75 B5.46%
2006-12-31A$2.61 B3.97%
2005-12-31A$2.51 B-7.06%
2004-12-31A$2.70 B